GO:0014911 positive regulation of smooth muscle cell migration: Vascular Remodeling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014911 describes any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
• Smooth muscle cell migration is a hallmark of vascular remodeling and contributes to neointimal hyperplasia, atherosclerosis and pulmonary hypertension.
• Key molecular drivers include FAT1 cadherin, Nrf3-Trim5 signaling, LDHA-mediated lactate production, KCNMB1 and miR-3154.
• The process is regulated by growth factors, matricellular proteins, metabolic cues and microRNAs that converge on cytoskeletal and adhesion dynamics.
• Loss-of-function and gain-of-function CRISPR models are essential to establish causality between candidate genes and smooth muscle cell migration.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect this pathway.
Description
Positive regulation of smooth muscle cell migration (GO:0014911) is a biological process that encompasses any signal or mechanism that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. Smooth muscle cells are not terminally static; in response to injury or pathological cues they switch to a synthetic, migratory phenotype that is central to vascular remodeling. This GO term therefore captures the upstream and intracellular events that license and propel smooth muscle cell movement, rather than the basal migration machinery itself. Understanding GO:0014911 is critical because dysregulated smooth muscle cell migration underlies major human diseases, including neointimal hyperplasia after vascular injury, atherosclerosis and pulmonary hypertension. Recent studies have identified specific molecular effectors such as the Nrf3-Trim5 axis, FAT1 cadherin, LDHA and KCNMB1 that positively regulate this process, providing tractable entry points for experimental interrogation. For researchers, GO:0014911 offers a structured framework to annotate genes, design functional assays and interpret transcriptomic or proteomic data in vascular biology.
positive regulation of smooth muscle cell migration At A Glance
| GO ID | GO:0014911 |
|---|---|
| GO term | positive regulation of smooth muscle cell migration |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. |
| Major function | Upregulation of smooth muscle cell motility during vascular remodeling, injury response and disease progression. |
| Representative regulators | Nrf3-Trim5 axis, FAT1 cadherin, LDHA, KCNMB1, miR-3154 |
| Associated diseases | Neointimal hyperplasia, atherosclerosis, pulmonary hypertension, abdominal aortic aneurysm |
| Research methods | Knockout, point mutation, knock-in, overexpression, CRISPR library screening, migration assays, transcriptomics and proteomics. |
What Is GO:0014911?
In our own words, GO:0014911 refers to any biological process that turns up, sustains or enhances the movement of smooth muscle cells. It is a positive regulatory node: it does not describe the core motility machinery itself, but the signals and effectors that increase how often, how fast or how far smooth muscle cells migrate. This includes growth factor signaling, cytoskeletal reorganization, adhesion turnover and metabolic or transcriptional programs that promote a migratory phenotype.
Why Is positive regulation of smooth muscle cell migration Important in Cell Biology?
GO:0014911 matters because smooth muscle cell migration is a double-edged sword: it is required for normal vascular repair but becomes pathogenic when chronically activated, driving neointimal hyperplasia, atherosclerotic plaque instability and pulmonary vascular remodeling. The term provides a precise annotation target for genes and pathways that positively regulate this migration, enabling researchers to distinguish causal drivers from bystander changes in complex vascular disease models.
• Smooth muscle cell migration is a hallmark of neointimal hyperplasia after angioplasty or stent injury.
• Positive regulation of this migration contributes to pulmonary vascular remodeling in pulmonary hypertension.
• Atherosclerosis progression involves matricellular protein-driven smooth muscle cell migration and phenotypic switching.
• Abdominal aortic aneurysm pathogenesis is linked to microRNA-mediated control of smooth muscle cell behavior, including miR-3154.
• FAT1 cadherin directly drives vascular smooth muscle cell migration, making it a model positive regulator.
• KCNMB1 reduction promotes smooth muscle cell phenotypic switch and apoptosis, indirectly affecting migratory capacity.
• Metabolic cues such as LDHA-mediated lactate generation can promote vascular remodeling.
• The Nrf3-Trim5 axis links oxidative stress responses to smooth muscle cell dysfunction and neointimal hyperplasia.
• GO:0014911 helps annotate single-cell and spatial transcriptomics data in vascular disease.
• CRISPR-based causality testing for this term supports target discovery for restenosis and pulmonary hypertension.
What Happens During positive regulation of smooth muscle cell migration?
Initiation by extracellular and metabolic cues
In simple terms: First, something outside or inside the cell tells the smooth muscle cell to start moving.
Positive regulation of smooth muscle cell migration begins when extracellular signals such as growth factors, matricellular proteins or metabolic stress activate receptors and downstream pathways. For example, LDHA-mediated lactate generation promotes pulmonary vascular remodeling, indicating that metabolic cues can initiate a migratory program. Matricellular proteins in the atherosclerotic microenvironment also provide pro-migratory signals.
Transcriptional and post-transcriptional control
In simple terms: The cell changes which genes are turned on or off to support movement.
Once triggered, transcriptional regulators and microRNAs modulate the expression of genes that promote migration. The Nrf3-Trim5 axis is a novel regulator of vascular smooth muscle cell dysfunction and neointimal hyperplasia, linking stress-responsive transcription to migratory behavior. miR-3154 has been identified as a pathogenic and therapeutic target in abdominal aortic aneurysm, where it influences smooth muscle cell function.
Cytoskeletal reorganization and adhesion dynamics
In simple terms: The cell reshapes its internal skeleton and grip points to physically move.
Positive regulation of migration requires coordinated actin cytoskeleton remodeling and turnover of focal adhesions. FAT1 cadherin drives vascular smooth muscle cell migration, likely by influencing adhesion and cytoskeletal signaling. KCNMB1 reduction leads to smooth muscle cell phenotypic switch, which can alter the balance between contractile and migratory states.
Phenotypic switching and sustained motility
In simple terms: The cell becomes a persistent mover rather than a static contractile cell.
Sustained positive regulation involves a phenotypic switch from contractile to synthetic/migratory smooth muscle cells. Reduced KCNMB1 expression promotes this switch and apoptosis, indirectly favoring a migratory phenotype in disease contexts. In atherosclerosis, matricellular proteins sustain this synthetic state and enhance migration.
Integration with vascular remodeling
In simple terms: The moving cells reorganize the vessel wall, which can be helpful or harmful.
Ultimately, positively regulated smooth muscle cell migration contributes to vascular remodeling. In neointimal hyperplasia, Nrf3-Trim5 signaling promotes smooth muscle cell dysfunction and neointimal formation. In pulmonary hypertension, LDHA-driven lactate production supports pulmonary vascular remodeling. These examples show how GO:0014911 integrates multiple upstream signals into a common pathological outcome.
Key Genes Involved in GO:0014911 positive regulation of smooth muscle cell migration
The following genes and proteins have been experimentally linked to positive regulation of smooth muscle cell migration or closely related vascular smooth muscle cell phenotypes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Nrf3 (NFE2L3) | Stress-responsive transcription factor; Nrf3-Trim5 axis promotes smooth muscle cell dysfunction and neointimal hyperplasia | Knockout and overexpression models to test causality in vascular injury |
| Trim5 | E3 ubiquitin ligase in the Nrf3-Trim5 axis; modulates smooth muscle cell phenotype | Point mutation and knockout to dissect ubiquitin-dependent regulation |
| LDHA | Lactate dehydrogenase A; lactate generation promotes pulmonary vascular remodeling | Metabolic knockout and overexpression models in pulmonary hypertension |
| miR-3154 | MicroRNA pathogenic and therapeutic target in abdominal aortic aneurysm | Knock-in and knockout of miRNA locus for aneurysm models |
| FAT1 | Cadherin that drives vascular smooth muscle cell migration | Knockout and tagged knock-in to track migration and adhesion |
| KCNMB1 | Potassium channel subunit; reduced expression leads to phenotypic switch and apoptosis | Knockout and point mutation to study contractile-to-synthetic switch |
| CX3CR1 | Macrophage receptor interacting with HSCs; relevant to tumor microenvironment | Knockout models to study immune-vascular crosstalk |
| FGFR4 | Receptor tyrosine kinase promoting CAF activation via CXCL10-CXCR3 | Overexpression and point mutation in stromal migration assays |
| CXCL10 | Chemokine in FGFR4-driven axis | Knockout and overexpression in co-culture migration assays |
| CXCR3 | Chemokine receptor mediating CXCL10 effects | Knockout and knock-in for chemotaxis studies |
| Matricellular proteins (e.g., thrombospondins, tenascins) | Extracellular matrix modulators in atherosclerosis | Overexpression and knockout in vascular smooth muscle cell cultures |
| CD8+ T cells (contextual) | Immune cells interacting with macrophages in HCC | Co-culture models to assess indirect regulation of migration |
| HSCs (contextual) | Hepatic stellate cells interacting with CX3CR1+ macrophages | Knockout and co-culture for microenvironment studies |
| CAFs (contextual) | Cancer-associated fibroblasts activated via FGFR4-CXCL10-CXCR3 | Overexpression and knockout in fibroblast migration assays |
| Nrf3-Trim5 downstream effectors | Mediate smooth muscle cell dysfunction | CRISPR library screening to identify downstream nodes |
| LDHA downstream metabolic targets | Link lactate to remodeling | Metabolomics and knockout models |
| miR-3154 targets | Mediate aneurysm pathogenesis | Target mimic and inhibitor studies with CRISPR validation |
| FAT1 adhesion complex components | Regulate cytoskeletal dynamics | Tagged knock-in and live imaging |
How Is positive regulation of smooth muscle cell migration Regulated?
Positive regulation of smooth muscle cell migration is controlled at multiple levels. Transcriptional regulation via the Nrf3-Trim5 axis links oxidative stress to smooth muscle cell dysfunction and neointimal hyperplasia. Metabolic regulation through LDHA-mediated lactate generation promotes pulmonary vascular remodeling. Post-transcriptional regulation by miR-3154 influences abdominal aortic aneurysm pathogenesis. Extracellular matrix and matricellular proteins in atherosclerosis provide contextual pro-migratory signals. Ion channel function, exemplified by KCNMB1, modulates the phenotypic switch that gates migratory capacity. Together, these layers form a regulatory network that can be interrogated with CRISPR-based perturbations.
positive regulation of smooth muscle cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Nrf3 (NFE2L3) | Neointimal hyperplasia | Smooth muscle cell-specific knockout mouse with carotid injury |
| LDHA | Pulmonary hypertension | Hypoxia-induced pulmonary hypertension in LDHA knockout mice |
| miR-3154 | Abdominal aortic aneurysm | miR-3154 knockout or knock-in mouse with angiotensin II infusion |
| FAT1 | Vascular smooth muscle cell migration | FAT1 knockout and tagged knock-in in primary smooth muscle cells |
| KCNMB1 | Smooth muscle cell phenotypic switch | KCNMB1 knockout and point-mutation cell models |
Neointimal hyperplasia and restenosis
Positive regulation of smooth muscle cell migration is a central driver of neointimal hyperplasia after vascular injury. The Nrf3-Trim5 axis promotes vascular smooth muscle cell dysfunction and neointimal hyperplasia, making it a candidate target for preventing restenosis. Experimental models typically use carotid artery ligation or balloon injury in mice with smooth muscle cell-specific knockouts.
Pulmonary hypertension
In pulmonary hypertension, LDHA-mediated lactate generation promotes pulmonary vascular remodeling, a process that includes enhanced smooth muscle cell migration. Targeting metabolic drivers such as LDHA may reduce pathological remodeling. Rodent models of hypoxia- or monocrotaline-induced pulmonary hypertension are commonly used to test this axis.
Atherosclerosis and abdominal aortic aneurysm
Atherosclerosis involves matricellular protein-driven smooth muscle cell migration and phenotypic switching. In abdominal aortic aneurysm, miR-3154 has been identified as a pathogenic and therapeutic target, highlighting post-transcriptional control of smooth muscle cell behavior. These diseases can be modeled in ApoE-/- or angiotensin II-infused mice with candidate gene perturbations.
Cancer microenvironment crosstalk
Although GO:0014911 is centered on smooth muscle cells, related migratory processes occur in tumor stroma. FGFR4 promotes cancer-associated fibroblast activation through the CXCL10-CXCR3 axis, and CX3CR1+ macrophages interact with hepatic stellate cells to promote hepatocellular carcinoma. These studies provide contextual evidence that positive regulation of migration-like programs in stromal cells contributes to cancer progression.
From positive regulation of smooth muscle cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is Nrf3 required for neointimal hyperplasia? | Smooth muscle cell-specific Nrf3 knockout mouse |
| Does LDHA-mediated lactate drive pulmonary remodeling? | LDHA knockout or overexpression in pulmonary artery smooth muscle cells |
| Does miR-3154 causally promote aneurysm? | miR-3154 knockout and knock-in mouse models |
| Does FAT1 directly drive migration? | FAT1 knockout and tagged knock-in in vascular smooth muscle cells |
| Does KCNMB1 loss alter phenotypic switch? | KCNMB1 knockout and point-mutation cell lines |
| Which downstream effectors mediate Nrf3-Trim5 signaling? | CRISPR library screening in smooth muscle cells |
How to Study the positive regulation of smooth muscle cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Testing candidate genes in smooth muscle cells |
| Scratch-wound assay | Rate of wound closure | Screening pro-migratory factors |
| RNA-seq | Global transcriptomic changes | Identifying pathways in vascular injury models |
| Single-cell RNA-seq | Cell-type-specific expression | Mapping smooth muscle cell phenotypic switch |
| Proteomics | Protein abundance and modifications | Cytoskeletal and adhesion changes |
| Live-cell imaging | Real-time cytoskeletal dynamics | Tagged knock-in of FAT1 or other regulators |
| CRISPR library screening | Gene fitness or migration phenotypes | Discovering novel regulators of GO:0014911 |
| Metabolomics | Lactate and metabolic intermediates | LDHA-driven remodeling studies |
Migration and invasion assays
Transwell and scratch-wound assays are standard to measure smooth muscle cell migration quantitatively. These assays can be combined with knockout or overexpression of candidate genes such as FAT1 or KCNMB1 to test positive regulation.
Transcriptomics and single-cell profiling
RNA-seq and single-cell RNA-seq can identify genes whose expression correlates with a migratory phenotype. For example, Nrf3-Trim5 axis components and miR-3154 targets can be mapped in vascular injury models.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can reveal changes in cytoskeletal and adhesion proteins during positive regulation of migration. This is particularly useful for pathways such as FAT1-mediated adhesion signaling.
Live-cell imaging and cytoskeletal dynamics
Live imaging of fluorescently tagged proteins (e.g., tagged knock-in of FAT1) allows real-time visualization of cytoskeletal reorganization and adhesion turnover during migration.
How CRISPR Can Be Used to Study GO:0014911 positive regulation of smooth muscle cell migration
Knockout
CRISPR knockout of candidate genes such as Nrf3, LDHA, FAT1 or KCNMB1 can test whether they are required for positive regulation of smooth muscle cell migration. Knockout models are typically validated by sequencing and protein loss, then subjected to migration assays.
Point Mutation
Point mutations can dissect specific residues or domains. For example, mutating the ubiquitin ligase domain of Trim5 or phosphorylation sites in FAT1 may reveal mechanistic details of positive regulation. These models are useful when complete knockout causes lethality or confounding phenotypes.
Knock-in
Knock-in of tags (e.g., GFP or HA) allows tracking of endogenous proteins such as FAT1 during migration. Knock-in of disease-associated variants in miR-3154 or KCNMB1 can model human genetics in isogenic cell lines.
Overexpression
Overexpression of pro-migratory genes like LDHA or Nrf3-Trim5 components can drive a migratory phenotype and test sufficiency. Overexpression models are often used in gain-of-function screens and for validating pathway activation.
How EDITGENE Supports positive regulation of smooth muscle cell migration Research
Researchers studying positive regulation of smooth muscle cell migration-related genes often need to determine whether a candidate gene is causally involved in driving or sustaining migration. EDITGENE provides a comprehensive suite of CRISPR-based services to establish causality, dissect mechanism and translate findings into disease models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of smooth muscle cell migration research.
Frequently Asked Questions About positive regulation of smooth muscle cell migration
What is GO:0014911?
GO:0014911 is the Gene Ontology term for positive regulation of smooth muscle cell migration, defined as any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
What genes are involved in positive regulation of smooth muscle cell migration?
Key genes include Nrf3, Trim5, LDHA, miR-3154, FAT1 and KCNMB1, among others.
How is smooth muscle cell migration measured?
Common methods include Transwell and scratch-wound assays, often combined with CRISPR perturbations.
What diseases involve positive regulation of smooth muscle cell migration?
Neointimal hyperplasia, pulmonary hypertension, atherosclerosis and abdominal aortic aneurysm are major examples.
What is the role of FAT1 in smooth muscle cell migration?
FAT1 cadherin drives vascular smooth muscle cell migration, likely through adhesion and cytoskeletal signaling.
How does LDHA promote vascular remodeling?
LDHA-mediated lactate generation promotes pulmonary vascular remodeling, which includes enhanced smooth muscle cell migration.
What is the Nrf3-Trim5 axis?
It is a signaling axis involving Nrf3 and Trim5 that promotes vascular smooth muscle cell dysfunction and neointimal hyperplasia.
Can CRISPR be used to study GO:0014911?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to test causality in smooth muscle cell migration.
What is the role of miR-3154 in abdominal aortic aneurysm?
miR-3154 has been identified as a pathogenic and therapeutic target in abdominal aortic aneurysm, influencing smooth muscle cell behavior.
How does KCNMB1 affect smooth muscle cells?
Reduced KCNMB1 expression leads to vascular smooth muscle cell phenotypic switch and apoptosis, indirectly affecting migration.
Conclusion
GO:0014911, positive regulation of smooth muscle cell migration, is a critical biological process that integrates transcriptional, metabolic, post-transcriptional and cytoskeletal signals to drive vascular remodeling. Its dysregulation contributes to neointimal hyperplasia, pulmonary hypertension, atherosclerosis and aneurysm. CRISPR-based functional genomics, combined with migration assays and multi-omics, offers a robust path to identify and validate causal regulators such as Nrf3, LDHA, FAT1 and KCNMB1. EDITGENE supports this research with end-to-end cell model and screening services.
References
- 1. Chen Q et al.. 2025. Novel roles of Nrf3-Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia.. Cardiovasc Res 121(8):1282-1298 PMID: 40377016
- 2. Wu D et al.. 2024. Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension.. J Transl Med 22(1):738 PMID: 39103838
- 3. Hou Q et al.. 2025. miR-3154: Novel Pathogenic and Therapeutic Target in Abdominal Aortic Aneurysm.. Circ Res 137(5):587-604 PMID: 40636968
- 4. Riascos-Bernal DF et al.. 2023. The FAT1 Cadherin Drives Vascular Smooth Muscle Cell Migration.. Cells 12(12) PMID: 37371091
- 5. Jeong JM et al.. 2025. CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression.. Hepatology 82(3):655-668 PMID: 40833997
- 6. Sun EG et al.. 2025. FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer.. Cell Death Dis 16(1):424 PMID: 40447617
- 7. Pervaiz N et al.. 2023. Matricellular proteins in atherosclerosis development.. Matrix Biol 120:1-23 PMID: 37086928
- 8. Liu H et al.. 2025. Reduced expression of KCNMB1 leads to vascular smooth muscle cell phenotypic switch and apoptosis.. Biochem Pharmacol 241:117151 PMID: 40653026
